Join us on 16th - 17th June online to master the art of crafting Standard Operating Procedures (SOPs) within regulated environments.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information15th May 2026
Summary:
The consultation sets out proposals to update and refine the regulatory framework for gene therapy medicinal products in the UK, reflecting rapid scientific advances and increasing use of these innovative treatments. It explores how current legislation applies to gene therapies, identifies areas where clarification or change may be needed, and invites feedback from stakeholders across the life sciences sector. The aim is to ensure that regulation supports innovation while maintaining robust safety, quality and efficacy standards for patients. The consultation also considers alignment with international approaches and how the UK can remain an attractive environment for development and clinical research in this field.